Comparison of the effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus
- PMID: 2850204
- DOI: 10.1016/0014-2999(88)90837-0
Comparison of the effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus
Abstract
The possible involvement of vasoactive intestinal polypeptide (VIP) in the non-adrenergic non-cholinergic (NANC) relaxation of the cat gastric fundus was studied in circular and longitudinal muscle strips. Cumulative transmural stimulation induced a frequency-dependent relaxation, while cumulative administration of VIP induced a concentration-dependent relaxation. Tetrodotoxin almost completely antagonized the relaxation induced by transmural stimulation (1 Hz), but did not influence the relaxation induced by VIP (10(-7) M); the latter was not influenced by hexamethonium or propranolol plus phentolamine. Trypsin (30 min incubation) and VIP antiserum (1 h incubation) prevented the relaxation induced by VIP and reduced that induced by transmural stimulation, but did not influence the relaxation induced by isopropylnoradrenaline. Two putative VIP receptor antagonists, [AcTyr1]hGRF-(1-40)OH and [4Cl-D-Phe6,Leu17]VIP, did not influence the relaxation induced by VIP or transmural stimulation. These results are compatible with the hypothesis that VIP is involved in the NANC relaxation of the cat gastric fundus, although participation of a non-VIP component cannot be excluded.
Similar articles
-
Is peptide histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus?Arch Int Pharmacodyn Ther. 1990 Jan-Feb;303:216-31. Arch Int Pharmacodyn Ther. 1990. PMID: 1973609
-
Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus.J Pharm Pharmacol. 1988 Oct;40(10):711-5. doi: 10.1111/j.2042-7158.1988.tb07000.x. J Pharm Pharmacol. 1988. PMID: 2907538
-
Study on the possible neurotransmitter of the non-adrenergic non-cholinergic innervation of the rat gastric fundus.Arch Int Pharmacodyn Ther. 1986 Apr;280(2 Suppl):110-36. Arch Int Pharmacodyn Ther. 1986. PMID: 2873800
-
Interaction of NO and VIP in gastrointestinal smooth muscle relaxation.Curr Pharm Des. 2004;10(20):2483-97. doi: 10.2174/1381612043383890. Curr Pharm Des. 2004. PMID: 15320758 Review.
-
VIP and autonomic neurotransmission.Pharmacol Ther. 1989;41(3):515-34. doi: 10.1016/0163-7258(89)90129-0. Pharmacol Ther. 1989. PMID: 2541454 Review.
Cited by
-
Transcriptional modulation by VIP: a rational target against inflammatory disease.Clin Epigenetics. 2011 Aug;2(2):213-22. doi: 10.1007/s13148-011-0036-4. Epub 2011 May 18. Clin Epigenetics. 2011. PMID: 22704338 Free PMC article.
-
Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.Clin Exp Immunol. 2009 Aug;157(2):225-34. doi: 10.1111/j.1365-2249.2009.03956.x. Clin Exp Immunol. 2009. PMID: 19604262 Free PMC article. Review.
-
Nitric oxide, an enteric nonadrenergic-noncholinergic relaxant transmitter: evidence using phosphodiesterase V and nitric oxide synthase inhibition.Br J Pharmacol. 1995 Sep;116(2):1789-96. doi: 10.1111/j.1476-5381.1995.tb16664.x. Br J Pharmacol. 1995. PMID: 8528561 Free PMC article.
-
Vasoactive intestinal peptide stimulation of renal adenylate cyclase and antagonism by (4Cl-D-Phe6Leu17)VIP.Pflugers Arch. 1989 Jun;414(2):222-7. doi: 10.1007/BF00580967. Pflugers Arch. 1989. PMID: 2755776
-
Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans.Gut. 2002 Aug;51(2):219-24. doi: 10.1136/gut.51.2.219. Gut. 2002. PMID: 12117883 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous